| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 55 |
| 1 | METHOTREXATE SODIUM | 55 |
| 2 | ASPIRIN | 52 |
| 3 | ASPIRIN 325 MG | 52 |
| 4 | ASPIRIN 81 MG | 52 |
| 5 | CLOPIDOGREL BISULFATE | 52 |
| 6 | METHOTREXATE | 50 |
| 7 | PREDNISONE | 48 |
| 8 | ADALIMUMAB | 44 |
| 9 | ALLOPURINOL | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALIFERMIN | 3 | 0.0077 |
| 1 | HYDROCORTISONE VALERATE | 4 | 0.0064 |
| 2 | CAMPHOR, CAPSAICIN, MENTHOL | 2 | 0.0038 |
| 3 | CLINDAMYCIN PHOSPHATE | 14 | 0.0025 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 18 | 0.0022 |
| 5 | PERINDOPRIL ERBUMINE | 12 | 0.0021 |
| 6 | ESTAZOLAM | 4 | 0.0020 |
| 7 | CEFUROXIME AXETIL | 7 | 0.0020 |
| 8 | IMIPENEM AND CILASTATIN SODIUM | 4 | 0.0019 |
| 9 | ALDESLEUKIN | 2 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 134 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 104 |
| 2 | Proton Pump Inhibitor [EPC] | 70 |
| 3 | Mood Stabilizer [EPC] | 54 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 52 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 51 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 50 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 47 |
| 8 | Benzodiazepine [EPC] | 45 |
| 9 | Loop Diuretic [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 3 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Paramagnetic Contrast Agent [EPC] | 5 | 0.0011 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 7 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 8 | Interleukin-17A Antagonist [EPC] | 34 | 0.0009 |
| 9 | beta Lactamase Inhibitor [EPC] | 4 | 0.0009 |